Human astrocytic brain tumors express APO2L/TRAIL

Acta Neuropathologica

Volumn 97, Issue 1, 1999, Pages 1-4

  Rieger, Johannes ^a   Ohgaki, Hiroko ^b   Kleihues, Paul ^b,c   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

APO2 ligand; CD95 ligand; Glioma

Indexed keywords

CYTOKINE; FAS ANTIGEN; HLA DR ANTIGEN; LIGAND; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN TUMOR; CELL CULTURE; CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NEOPLASM; NERVE CELL; PRIORITY JOURNAL;

ADULT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOBLOTTING; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033001788     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050948     Document Type: Article

References (17)

1. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang C-P, DuBose RF, Goodwin RG, Smith CA (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186: 1165-1170
2. Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, Tachibana O, Kleihues P, Ohgaki H (1997) Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol 7:863-869
3. Mariani SM, Krammer PH (1998) Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 28: 1492-1498
4. Mariani SM, Matiba B, Armandola EA, Krammer PH (1997) Interleukin-1 β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 137:221-229
5. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A (1996) Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 6: 750-752
6. Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A (1997) A novel receptor for APO2L/TRAIL contains a truncated death domain. Curr Biol 7: 1003-1006
7. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113
8. Pan G, Ni J, Wei Y-F, Yu G-L, Gentz R, Dixit VM (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818
9. Pan G, Ni J, Yu G-L, Wei Y-F, Dixit VM (1998) TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 424:41-45
10. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690
11. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M (1998) APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 427: 124-128
12. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Meir EG van, Tribolet N de, Tschopp J, Dietrich PY (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 9: 1173-1178
13. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a familiy of signaling and decoy receptors. Science 277:818-821
14. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16:5386-5397
15. Weller M, Weinstock C, Will C, Wagenknecht B, Dichgans J, Lang F, Gulbins E (1997) CD95-dependent T-cell killing by glioma cells expressing CD95 ligand: more on tumor escape, the CD95 counterattack, and the immune privilege of the brain. Cell Physiol Biochem 7:282-288
16. Weller M, Kleihues P, Dichgans J, Ohgaki H (1998) CD95 ligand: lethal weapon for malignant glioma? Brain Pathol 8: 285-293
17. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholl JK, Sutherland CR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682